{"disease":{"id":"potentially-resection","name":"potentially resection"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03591705","title":"TACE-HAIC vs. HAIC for Potentially Resectable HCC","phase":"NA","overall_status":"UNKNOWN","enrollment_count":240,"lead_sponsor_name":"Sun Yat-sen University","has_results":false}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}